Citations

Showing 10 of 108104 citations.

Subclinical High Resolution Chest CT Scan Features In Psoriasis
Al‐Qarqaz, Firas , Bataineh, Zineb, Ramadan, Anoud, Zubaidi, Ghid Al, Alwani, Mustafa , Abualnaaj, Dina, Za’nouneh, Fares J. Abu, Zoubi, Khalid Al, Samrah, Randa S. , Kubbara, Aahd , Samrah, Shaher M. , Obeidat, Omar , Khassawneh, Basheer Y.

Mayo Clinic

No container title available | March 16, 2022 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.21203/rs.3.rs-1406730/v1 Get It

Abstract Background: Although psoriasis is considered a systemic disease, no clear association has been established between psoriasis and lung diseases. Methods: Adult psoriasis patients with no known active pulmonary disease or respiratory symptoms were screened for subclinical pulmonary manifestations and possible parenchymal changes using high-resolution computed tomography (HRCT) scan of the chest. Patients were classified according to the severity of skin manifestations. The clinical characteristics and radiographic findings of these patients were evaluated.Results: A total of 59 patients with psoriasis were included, among which 47 (79.7%) had abnormal HRCT scan features. Micronodules were the most common detected lung lesions (66.1%), followed by interlobular septal thickening (23.7%), fibrosis (11.9%), and ground-glass opacity (6.8%). Other HRCT findings included emphysematous changes and calcified granulomas. Abnormal HRCT findings correlated with older age and duration of psoriasis but not with the severity of skin manifestations.Conclusions: Micronodules and interlobular septal thickening were the most detected lung lesions in patients with psoriasis. These findings of the pilot study highlight the possible pulmonary involvement in patients with psoriasis. Larger multicenter studies are needed to further clarify these findings.
Benefit of Continuous Glucose Monitoring in Reducing Hypoglycemia Is Sustained Through 12 Months of Use Among Older Adults with Type 1 Diabetes
Miller, Kellee M. , Kanapka, Lauren , Ahmann, Andrew , Ang, Lynn , Bhargava, Anuj , Bode, Bruce W. , Carlson, Anders L. , Chaytor, Naomi , Gannon, Gail, Goland, Robin, Kiblinger, Lisa, Kruger, Davida , Kudva, Yogish C. , O’Malley, Grenye , Philis‐Tsimikas, Athena , Salam, Maamoun , Thompson, Michael , Vendrame, Francesco , Verdejo, Alandra , Weinstock, Ruth S. , Young, Laura , Group, for the WISDM Study, Kanapka, Lauren G , Kudva, Yogish C. , Peters, Anne L , Philis-Tsimikas, Athena , Shah, Viral N , Weinstock, Ruth S , Rickels, Michael R. , Aleppo, Grazia , Hirsch, Irl B. , Levy, Carol J. , McGill, Janet B. , Peters, Anne L. , Philipson, Louis H. , Pop‐Busui, Rodica , Shah, Viral N. , Pratley, Richard E. , Group, for the WISDM Study

Mayo Clinic

Diabetes Technology & Therapeutics | March 16, 2022 | Volume: 24 | Issue: 6 | Pages: 424-434

10.1089/dia.2021.0503 | PMID 35294272 Get It

Objective: To evaluate glycemic outcomes in the Wireless Innovation for Seniors with Diabetes Mellitus (WISDM) randomized clinical trial (RCT) participants during an observational extension phase. Research Design and Methods: WISDM RCT was a 26-week RCT comparing continuous glucose monitoring (CGM) with blood glucose monitoring (BGM) in 203 adults aged ≥60 years with type 1 diabetes. Of the 198 participants who completed the RCT, 100 (98%) CGM group participants continued CGM (CGM-CGM cohort) and 94 (98%) BGM group participants initiated CGM (BGM-CGM cohort) for an additional 26 weeks. Results: CGM was used a median of >90% of the time at 52 weeks in both cohorts. In the CGM-CGM cohort, median time <70 mg/dL decreased from 5.0% at baseline to 2.6% at 26 weeks and remained stable with a median of 2.8% at 52 weeks ( P < 0.001 baseline to 52 weeks). Participants spent more time in range 70–180 mg/dL (TIR) (mean 56% vs. 64%; P < 0.001) and had lower hemoglobin A1c (HbA1c) (mean 7.6% [59 mmol/mol] vs. 7.4% [57 mmol/mol]; P = 0.01) from baseline to 52 weeks. In BGM-CGM, from 26 to 52 weeks median time <70 mg/dL decreased from 3.9% to 1.9% ( P < 0.001), TIR increased from 56% to 60% ( P = 0.006) and HbA1c decreased from 7.5% (58 mmol/mol) to 7.3% (57 mmol/mol) ( P = 0.025). In BGM-CGM, a severe hypoglycemic event was reported for nine participants while using BGM during the RCT and for two participants during the extension phase with CGM ( P = 0.02). Conclusions: CGM use reduced hypoglycemia without increasing hyperglycemia in older adults with type 1 diabetes. These data provide further evidence for fully integrating CGM into clinical practice. Clinicaltrials.gov (NCT03240432)
Palliative Care and Pulmonary Arterial Hypertension
Rhee, Laura S., Morgan, Alisha, DuBrock, Hilary M.

Mayo Clinic

Advances in Pulmonary Hypertension | March 16, 2022 | Volume: 21 | Issue: 1 | Pages: 7-11

10.21693/1933-088x-21.1.7 Get It

Background Pulmonary arterial hypertension (PAH) is a chronic and progressive disease associated with impaired health-related quality of life and survival. Palliative care (PC) is patient- and family-centered care provided by an interdisciplinary team with an overarching goal of alleviating suffering and improving quality of life for patients with advanced illness. PC in other chronic diseases is associated with improved quality of life, symptom management, illness understanding, and reduced caregiver burden, but there is limited data regarding PC in PAH. Despite limited evidence, there is strong rationale for involving PC specialists in the longitudinal management of PAH. Implications for Clinicians There are currently no guidelines to help clinicians determine the most appropriate timing for referral of PAH patients to PC specialty teams. Consequently, referrals are limited and often delayed. Adoption of a standardized approach to PC referrals based on clinical or patient triggers could facilitate earlier involvement of PC as an adjunct to ongoing PAH disease-directed care. Conclusions Incorporation of PC in the longitudinal management of PAH may be beneficial to address the multidimensional aspects of living with a chronic and life-limiting illness.
Ann’s Final Gift
Lin, Keldon K., Lin, Keldon K. , Lin, Keldon K.

Mayo Clinic

Academic Medicine | March 16, 2022 | Volume: 97 | Issue: 6 | Pages: 785-785

10.1097/acm.0000000000004668 | PMID 35294402 Get It

The Effects of Obesity and Bariatric Surgery on Rates of Upper Extremity Compression Neuropathies
Maasarani, Samantha , Thomson, Kyle B. , Becerra, Adán Z. , Adogwa, Owoicho , Mehta, Ankit I. , Noland, Shelley S. , Torquati, Alfonso , Pires, Giovanna R, Khalid, Syed , Pires, Giovanna Rodosli

Mayo Clinic

Annals of Surgery Open | March 16, 2022 | Volume: 3 | Issue: 1 | Pages: e146

10.1097/as9.0000000000000146 | PMID 37600109 Get It

Objectives: To estimate the effects of obesity on all types of upper extremity compression neuropathies (UECN) (carpal tunnel syndrome and other median nerve, radial nerve, and ulnar nerve compression neuropathies) and to assess whether bariatric surgery modifies these effects. Background: UECN are increasingly prevalent and decrease the quality of life of affected individuals. Studies suggest obesity as a risk factor for carpal tunnel syndrome, the most common type of UECN. Methods: A retrospective cohort study was conducted using the PearlDiver Mariner Database, an all-payor claims database containing claims for over 53 million patients from 2010 to 2019 in all 50 US states. Rates and odds of all types of UECN were compared between 1:1:1 exact matched cohorts of obese patients who were medically managed, obese patients who underwent bariatric surgery, and nonobese patients (111,967 patients in each cohort). Results: Compared with nonobese patients, patients with obesity were significantly more likely to develop any UECN (odds ratio [OR], 1.13; 95% confidence interval [CI], 1.09–1.18), carpal tunnel syndrome (OR, 1.15; 95% CI, 1.10–1.30), and 2 or more UECN (OR, 1.34; 95% CI, 1.20–1.48). Compared with obese patients who were managed medically, obese patients who underwent bariatric surgery were significantly less likely to develop any UECN (OR, 0.87; 95% CI, 0.84–0.91) and carpal tunnel syndrome (OR, 0.85; 95% CI, 0.81–0.89). Conclusions: Obese patients have higher odds of both single and concomitant UECN, specifically carpal tunnel syndrome, compared with nonobese patients. Bariatric surgery decreases the odds of developing UECN compared with obese patients not undergoing surgical intervention.
Diagnosis of Primary Scrotal Lymphedema Using 99mTc-Sulfur Colloid Lymphoscintigram
Rhee, Annie, Casey, William J., Roarke, Michael C., Rebecca, Alanna M. , Flug, Jonathan A. , Yang, Ming

Mayo Clinic

Clinical Nuclear Medicine | March 16, 2022 | Volume: 47 | Issue: 5 | Pages: e417-e418

10.1097/rlu.0000000000004132 | PMID 35293355 Get It

Abstract We report a case of a 19-year-old man who presented with severe scrotal swelling. His medical history was notable for severe global edema at birth. Most areas of swelling had resolved by adolescence with exception of the scrotum and the left lower extremity. 99mTc-filtered sulfur colloid lymphoscintigraphy of the lower extremities demonstrated prominent dermal backflow into the superficial scrotum and thighs, which were confirmed on the SPECT/CT images, and correlated with findings on MR lymphangiogram. Lymphoscintigram and MR lymphangiogram may provide complementary information to aid diagnosis and management of primary scrotal lymphedema.
Psychometric properties of outcome measurement instruments for ANCA-associated vasculitis: a systematic literature review
Berti, Alvise , Boleto, Gonçalo , Tómasson, Gunnar , Monti, Sara , Carmona, Loreto , Ramiro, Sofía , Monti, Sara , Quinn, Kaitlin A , Hassett, Leslie C. , Carmona, Loreto , Ramiro, Sofia , Berti, Alvise , Merkel, Peter A.

Mayo Clinic

Rheumatology | March 16, 2022 | Volume: 61 | Issue: 12 | Pages: 4603-4618

10.1093/rheumatology/keac175 | PMID 35293985 Get It

Abstract Objectives To systematically review the psychometric properties of outcome measurement instruments used in ANCA-associated vasculitis (AAV). Methods Medline, EMBASE, Cochrane, Scopus and Web of Science were searched from inception to 14 July 2020 for validation studies of instruments used in AAV. Following the COnsensus-based Standards for the selection of health status Measurement INstruments (COSMIN) and OMERACT frameworks, different psychometric properties (validity, reliability, responsiveness and feasibility) were summarized. Risk of bias was assessed according to the COSMIN checklist. Results From 2505 articles identified, 32 met the predefined selection criteria, providing information on 22 instruments assessing disease activity (n = 7), damage (n = 2), activity and damage (n = 1), health-related quality of life (HRQoL; n = 9) and function (n = 3). Most of the instruments were tested in AAV as a group or in granulomatosis with polyangiitis only. The BVAS, any version, the Vasculitis Damage Index (VDI) and the AAV-Patient-Reported Outcome (AAV-PRO) have been more extensively validated than the other instruments. BVAS for Wegener Granulomatosis (BVAS/WG) has been shown to be valid for measuring disease activity [correlation with Physician global assessment (r = 0.90)], reliability (inter-observer intraclass correlation coefficient = 0.97), responsiveness and feasibility. For damage, VDI was shown to be moderately valid (correlations with BVAS version 3 at 6 months r = 0.14, BVAS/WG at 1 year r = 0.40 and 5 years r = 0.20), and feasible. For HRQoL, AAV-PRO demonstrated validity (correlations of the six AAV-PRO domains with EQ-5D-5L: −0.78 to −0.55; discrimination between active disease and remission, P &lt; 0.0001 for all comparisons). The overall performance of instruments assessing function was low-to-moderate. Conclusion Among the 22 outcome measurement instruments used for AAV, BVAS (any version), VDI and AAV-PRO had the strongest psychometric properties.
Multimodality imaging of cardiac involvement in Erdheim–Chester disease
Quinn, Erina , Mahowald, Madeline , Goyal, Gaurav , Goyal, Guarav , Mahowald, Madeline K , Go, Ronald S. , Young, Jason R.

Mayo Clinic

European Heart Journal - Cardiovascular Imaging | March 16, 2022 | Volume: 23 | Issue: 7 | Pages: e276-e276

10.1093/ehjci/jeac063 | PMID 35383378 Get It

Recommendations for standardizing biopsy acquisition and histological assessment of immune checkpoint inhibitor-associated colitis
Ma, Christopher , Pai, Rish K. , Krell, Jonathan , Guizzetti, Leonardo , McFarlane, Stefanie C., MacDonald, John K, Choi, Won‐Tak , Feakins, Roger , Kirsch, Richard , Lauwers, Gregory Y. , Pai, Reetesh K. , Rosty, Christophe , Srivastava, Amitabh , Walsh, Joanna C. , Feagan, Brian G. , Ma, C , Guizzetti, L , Rosty, Christophe , Srivastava, Amitabh , Schaeffer, David F. , Jairath, Vipul

Mayo Clinic

Journal for ImmunoTherapy of Cancer | March 16, 2022 | Volume: 10 | Issue: 3 | Pages: e004560

10.1136/jitc-2022-004560 | PMID 35296560 Get It

Immune checkpoint inhibitor-associated colitis (ICIC) affects approximately 15% of cancer patients treated with immunotherapy. Although histological evaluation is potentially valuable for both the diagnosis of ICIC and evaluation of disease activity, use in clinical practice is heterogeneous. We aimed to develop expert recommendations to standardize histological assessment of disease activity in patients with ICIC. Using the modified Research and Development/University of California Los Angeles (RAND/UCLA) appropriateness methodology, an international panel of 11 pathologists rated the appropriateness of 99 statements on a 9-point Likert scale during two rounds of anonymous voting. Results were discussed between rounds using moderated videoconferences. There are currently no disease-specific instruments for assessing histological features of ICIC. The panel considered that colonoscopy with at least three biopsies per segment from a total of at least five segments, including both endoscopically normal and inflamed areas, was appropriate for tissue acquisition. They agreed that biopsies should be oriented such that the long axis of the colonic crypts is visualized and should be stained with hematoxylin and eosin. Histological items that the panel voted were appropriate to evaluate in ICIC included the degree of structural/architectural change, chronic inflammatory infiltrate, lamina propria and intraepithelial neutrophils, crypt abscesses and destruction, erosions/ulcerations, apoptosis, surface intraepithelial lymphocytosis, and subepithelial collagen thickness. The appropriateness of routine immunohistochemistry was uncertain. These expert recommendations will help standardize assessment of histological activity in patients with ICIC. The panel also identified the development and validation of an ICIC-specific histological index as a research priority.
Midazolam and delirium: can you have it both ways?
Greengrass, Roy A.

Mayo Clinic

Regional Anesthesia & Pain Medicine | March 16, 2022 | Volume: 47 | Issue: 7 | Pages: 449.2-450

10.1136/rapm-2022-103607 | PMID 35296540 Get It